# Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

> **NCT01323673** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 125 (actual)

## Conditions studied

- Dermatitis, Chronic

## Interventions

- **DRUG:** clobetasol propionate 0.05%
- **DRUG:** Vehicle / Placebo

## Key facts

- **NCT ID:** NCT01323673
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-15
- **Primary completion:** 2011-03-01
- **Final completion:** 2011-03-29
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2018-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01323673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01323673, "Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01323673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*